As we expand our partnership with Pfizer in the company’s most significant agreement to date, we find ourselves thinking about the CytoReason “growth factor”—the key agent to our company’s success. Though we work at the forefront of cutting-edge biotechnology and science, the answer is surprisingly simple: collaboration.
CytoReason’s growth can be seen much like that of the human body. The two biggest factors impacting growth are internal (nature) and external (nurture). Internally, growth is led by genetic inheritance and other biological factors. Externally, growth is led by interactions with the outside environment – the food we eat, the experiences we have, the people surrounding us.
The key here is collaboration. The constant synergy of internal and external systems enables our body to develop and thrive.
CytoReason’s internal collaboration manifests itself in the unique cooperation of our immunologists and bioinformaticians. Like distinct organs, their roles appear very different – an immunologist studies the biological mechanisms of a disease, while a bioinformatician uses programming and statistical modeling to analyze data. But at CytoReason, the direct partnership between these two roles could not be more important.
When a client asks us which patient’s might benefit from a potential drug, for example, our immunologists and bioinformaticians combine their respective clinical and computational knowledge to first identify the biological questions underlying the client’s query. Then, using these questions as a guide, they determine together what kinds of data and analysis should be used. They don’t merely exchange emails or communicate on slack. They work side-by-side in the same room and speak the same scientific language.
Just as a growing body is influenced by its environment, CytoReason also grows through its client partnerships. Pfizer has played a major role in accelerating our growth. When our computational disease models were in their earliest stages, Pfizer asked us complex questions that pushed us to adapt and advance our technological capabilities. What’s more, no matter the project, there was always someone at Pfizer who believed in us and championed our technology – encouraging us to persist and promoting us within new research departments. In return, CytoReason’s collaborative nature fostered greater unity across Pfizer’s own teams, bringing together researchers of all levels in the organization.
Though we’ve come a long way since we started in 2016, CytoReason’s growth has only just begun. As we welcome new employees, we expand our capacity for internal cooperation and intellectual exchange. As we enter new partnerships, we meet challenging environments that push us to develop better, more powerful models. And we believe this growth – internal and external – is charting new boundaries and defining the future of pharma R&D.
Accessibility | Terms of Use | Privacy Policy | All rights reserved CytoReason LTD © 2022 | Designed and Developed by: Webnoise